Medical Biomimetics Market Competitive Analysis with Abbott, AVINENT Implant System S.L.U., BioHorizons, BioMiMetiC, Forschungszentrum Jülich, Hstar Technologies, Helmholtz, SynTouch, Veryan Medical

Growing advancements in nanotechnology will assist global medical biomimetics market growth in the forthcoming years. Nanotechnology possesses potential to illustrate single molecules/cells at very high output and shows dynamic biomimetic behaviour. Such advancements can yield development of personalized medicine. Nanoparticles can exhibit progressive functions including response to stimuli, targeting cell/organ, imaging as well as drug delivery. Such beneficial capabilities along with continuous advancements will positively impact biomimetic market growth in coming years.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/767

Favourable funding scenario for research and development of biomimetics will boost medical biomimetics industry growth. Several universities in Europe are receiving funding for conducting research on biomimetics. Additionally, numerous organizations and institutes are undertaking collaborative approach for advancements in biomimetics that should highly impact medical biomimetics market growth over the foreseeable future.


Expanding geriatric population base will positively influence medical biomimetics business growth. Elderly population is highly susceptible to suffer from cardiovascular diseases, orthopaedic diseases as well as neurological disorders. As per American Heart Association, about 43.7 million Americans aged above 60 years of age suffer from at least one form of cardiovascular disease. Hence, increasing utilization of biomimetics in cardiovascular field will augment the market growth in the forecast period. However, presence of restrictive regulatory scenario may hamper medical biomimetics industry growth in forthcoming years.

Cardiovascular medical biomimetics product segment accounted USD 8.4 billion in 2017. With assistance of tissue regeneration and biomimetics, several advanced products are being developed to cure cardiac disorders at chronic stages. Such tissues with the help of biomimetic technology improve cardiac function. Thus, increasing prevalence as well as mortalities due to CVD should increase the adoption of medical biomimetics product in upcoming years.

Browse Full Report Details @ https://www.gminsights.com/industry-analysis/medical-biomimetics-market

Orthopaedic medical biomimetics product segment will progress at 5.8% CAGR throughout the forecast period. Biomimetic bones are designed that imitate natural bone structure that can be used in patients with walking disabilities. Biomimetics has developed novel hip prostheses carrying characteristics similar to contiguous bone that should increase the product demand. With rising road accidents coupled with growing demand for prostheses, orthopaedic product segment growth will spur in the upcoming years.

Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:

 Abbott
 AVINENT Implant System S.L.U.
 BioHorizons
 BioMiMetiC
 Forschungszentrum Jülich
 Hstar Technologies
 Helmholtz
 SynTouch
 Veryan Medical

Drug delivery application segment accounted for over USD 6.5 billion market size in 2017 and is estimated to dominate the global medical biomimetics market throughout the projected timeframe. Better performance of vaccines as well as accurate drug delivery of nanocarriers through biomimetic devices will accelerate market growth. For instance, biomimetic drug delivery carrier such as recombinant bacteria are used for vaccine delivery. Such continuous R&D activities along with new product launch will highly impact medical biomimetics market growth.

Tissue engineering application segment is poised to grow at 6.0% CAGR during the projected timeframe. Advancements such as biomaterials that imitate natural extracellular matrix for tissue regeneration will stimulate segmental growth. The technique of tissue engineering restores damaged tissues by merging cells from the body with biomimetic materials. Increasing application of biomimetics in organ regeneration will thus impel segmental growth in upcoming years.

U.S. medical biomimetics market dominated North America industry with over 85% market share in 2017. Growing burden of chronic diseases coupled with aging population will offer lucrative medical biomimetics industry growth potential in coming years. According to CDC, about 6 among 10 adults in the U.S. suffer from chronic diseases. Additionally, increasing adoption of non-invasive cosmetic surgeries should drive the demand for medical biomimetics product.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/767

Japan medical biomimetics market held USD 1.0 billion in 2017. High growth is attributable to growing R&D activities, rapid adoption of innovative products and partnerships. For instance, 3B’s Research Group established long-term partnership with universities across Asia. In addition, growing healthcare infrastructure as well as funding in the country will boost Japan medical biomimetics industry growth.

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com
Blog: http://solutionrocket.com

This release was published on openPR.